Cargando…
Optimal global spending for group A Streptococcus vaccine research and development
Group A Streptococcus (Strep A) leads to 600,000 deaths and 600 million cases of pharyngitis annually. Although long a promising target for vaccine development, how much funding should be allocated to develop a Strep A vaccine is unclear. We aim to calculate the optimal amount of global spending for...
Autores principales: | Tortorice, Daniel, Ferranna, Maddalena, Bloom, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125865/ https://www.ncbi.nlm.nih.gov/pubmed/37185380 http://dx.doi.org/10.1038/s41541-023-00646-6 |
Ejemplares similares
-
COVID-19 Vaccine Allocation: Modeling Health Outcomes and Equity Implications of Alternative Strategies
por: Ferranna, Maddalena, et al.
Publicado: (2021) -
Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption
por: Bennett, Neil G., et al.
Publicado: (2022) -
Social determinants of mortality from COVID-19: A simulation study using NHANES
por: Seligman, Benjamin, et al.
Publicado: (2021) -
Correction: Social determinants of mortality from COVID-19: A simulation study using NHANES
por: Seligman, Benjamin, et al.
Publicado: (2021) -
The full health, economic, and social benefits of prospective Strep A vaccination
por: Cadarette, Daniel, et al.
Publicado: (2023)